Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 2
1956 1
1958 3
1961 1
1963 1
1964 1
1965 2
1966 4
1967 8
1968 8
1969 11
1970 5
1971 3
1972 10
1973 9
1974 11
1975 9
1976 6
1977 5
1978 5
1979 9
1980 11
1981 23
1982 16
1983 35
1984 25
1985 26
1986 23
1987 32
1988 33
1989 22
1990 29
1991 39
1992 60
1993 38
1994 44
1995 57
1996 57
1997 48
1998 52
1999 53
2000 39
2001 45
2002 50
2003 38
2004 42
2005 29
2006 48
2007 53
2008 56
2009 64
2010 74
2011 75
2012 93
2013 76
2014 67
2015 78
2016 95
2017 107
2018 123
2019 131
2020 134
2021 183
2022 184
2023 200
2024 174

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,817 results

Results by year

Filters applied: . Clear all
Page 1
Endovascular Therapy for Acute Stroke with a Large Ischemic Region.
Yoshimura S, Sakai N, Yamagami H, Uchida K, Beppu M, Toyoda K, Matsumaru Y, Matsumoto Y, Kimura K, Takeuchi M, Yazawa Y, Kimura N, Shigeta K, Imamura H, Suzuki I, Enomoto Y, Tokunaga S, Morita K, Sakakibara F, Kinjo N, Saito T, Ishikura R, Inoue M, Morimoto T. Yoshimura S, et al. Among authors: morimoto t. N Engl J Med. 2022 Apr 7;386(14):1303-1313. doi: 10.1056/NEJMoa2118191. Epub 2022 Feb 9. N Engl J Med. 2022. PMID: 35138767 Clinical Trial.
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators. Watanabe H, et al. Among authors: morimoto t. JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145. JAMA. 2019. PMID: 31237644 Free PMC article. Clinical Trial.
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.
Fujimoto D, Morimoto T, Tamiya M, Hata A, Matsumoto H, Nakamura A, Yokoyama T, Taniguchi Y, Uchida J, Sato Y, Yokoi T, Tanaka H, Furuya N, Masuda T, Sakata Y, Miyauchi E, Hara S, Saito G, Miura S, Kanazu M, Yamamoto N, Akamatsu H. Fujimoto D, et al. Among authors: morimoto t. JAMA Netw Open. 2023 Feb 1;6(2):e230698. doi: 10.1001/jamanetworkopen.2023.0698. JAMA Netw Open. 2023. PMID: 36826813 Free PMC article.
VTE and anti-coagulation therapy in cancer patients.
Miyazaki Y, Sase K, Hasegawa K, Morimoto T. Miyazaki Y, et al. Among authors: morimoto t. Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):189-191. doi: 10.1093/ehjcvp/pvz027. Eur Heart J Cardiovasc Pharmacother. 2019. PMID: 31378809 No abstract available.
Functional hearing loss and developmental imbalances.
Yamazaki M, Kawase T, Hino-Fukuyo N, Morimoto T, Metoki H, Takahashi H, Fukuchi N, Takanashi Y, Ohta N. Yamazaki M, et al. Among authors: morimoto t. Int J Pediatr Otorhinolaryngol. 2023 Oct;173:111700. doi: 10.1016/j.ijporl.2023.111700. Epub 2023 Aug 16. Int J Pediatr Otorhinolaryngol. 2023. PMID: 37633125
Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants.
Kaneda K, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Kimura T; COMMAND VTE Registry-2 Investigators. Kaneda K, et al. Among authors: morimoto t. Eur J Intern Med. 2023 Dec;118:59-72. doi: 10.1016/j.ejim.2023.08.007. Epub 2023 Aug 11. Eur J Intern Med. 2023. PMID: 37574348 Free article.
Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention.
Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Natsuaki M, Watanabe H, Yamaji K, Ohya M, Nakamura S, Mitomo S, Suwa S, Domei T, Tatsushima S, Ono K, Sakamoto H, Shimamura K, Shigetoshi M, Taniguchi R, Nishimoto Y, Okayama H, Matsuda K, Yokomatsu T, Muto M, Kawaguchi R, Kishi K, Hadase M, Fujita T, Nishida Y, Nishino M, Otake H, Suematsu N, Ajimi T, Tanabe K, Abe M, Hibi K, Kadota K, Ando K, Kimura T; OPTIVUS-Complex PCI Investigators*. Yamamoto K, et al. Among authors: morimoto t. Circ Cardiovasc Interv. 2023 May;16(5):e012922. doi: 10.1161/CIRCINTERVENTIONS.123.012922. Epub 2023 May 16. Circ Cardiovasc Interv. 2023. PMID: 37192307
2,817 results